article thumbnail

Should we be worried about pharma’s supply chain?

World of DTC Marketing

We need a 21st-century approach that puts patient safety first. The US Food and Drug Administration (FDA) believes the adulteration of heparin was an economically motivated act—a clear breach of the US pharmaceutical supply chain. In other words, money over safety. The question that I kept asking was why?

article thumbnail

US legislative update: takeaways for European pharma

European Pharmaceutical Review

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. Actavis, 570 U.S. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. The Andaman7 Platform Solution. Vincent Keunen.

article thumbnail

Everything You Need to Know About Market Access in China

PM360

Medicines that are not listed in either Category 1 or 2, such as over the counter (OTC) and other prescription therapies (pembrolizumab, CAR-T therapy, etc.), During the application stage, manufacturers should formulate principles and prepare a value dossier which is structuralized in a similar way as a classic payer value story.

Marketing 105
article thumbnail

Solving pharma’s process development challenges one API at a time

Pharmaceutical Technology

If clinical trials prove successful, that same process should then be scaled to commercial manufacturing. A large part of process development involves the selection of pharmaceutical manufacturing equipment for blending, extrusion, drying, milling, and micronization. One size (never) fits all.